N
LEGN icon

Natixis’s Legend Biotech LEGN Stock Holding History

Natixis’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.4K Hold
1,157
– – ﹤0.01% 1045
2026
Q1 		$20.9K Hold
1,157
– – ﹤0.01% 1008
2025
Q4 		$25.2K Buy
1,157
+437
+61% +$12.5K ﹤0.01% 1028
2025
Q3 		$23.5K Hold
720
– – ﹤0.01% 960
2025
Q2 		$25.6K Sell
720
-65
-8% -$2.11K ﹤0.01% 918
2025
Q1 		$26K Sell
785
-64
-8% -$2.29K ﹤0.01% 859
2024
Q4 		$27.6K Sell
849
-162
-16% -$6.71K ﹤0.01% 919
2024
Q3 		$49.3K Sell
1,011
-54
-5% -$2.88K ﹤0.01% 787
2024
Q2 		$47.2K Sell
1,065
-339
-24% -$15.6K ﹤0.01% 788
2024
Q1 		$78.8K Sell
1,404
-618
-31% -$37.3K ﹤0.01% 795
2023
Q4 		$122K Sell
2,022
-106
-5% -$6.72K ﹤0.01% 762
2023
Q3 		$143K Sell
2,128
-993
-32% -$69K ﹤0.01% 749
2023
Q2 		$215K Sell
3,121
-702
-18% -$45.9K ﹤0.01% 733
2023
Q1 		$184K Sell
3,823
-237
-6% -$11.6K ﹤0.01% 751
2022
Q4 		$203K Buy
+4,060
New +$197K ﹤0.01% 821
2022
Q2 		– Sell
-7,974
Closed -$290K – 1271
2022
Q1 		$290K Sell
7,974
-108
-1% -$4.27K ﹤0.01% 1070
2021
Q4 		$377K Buy
8,082
+686
+9% +$34.8K ﹤0.01% 1086
2021
Q3 		$372K Buy
+7,396
New +$308K ﹤0.01% 1060

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Natixis's LEGN Position: Q2 2026 in Review

Natixis held its Legend Biotech (LEGN) position steady in Q2 2026 at 1,157 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1045.

Natixis first reported a position in LEGN in Q3 2021 and has held it in 18 quarters since. The position peaked at $377K in Q4 2021. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Natixis held 1,157 shares of Legend Biotech worth $33.4K as of Q2 2026.
  • Natixis left its Legend Biotech share count unchanged in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Natixis's portfolio in Q2 2026, its #1045 holding.
  • Natixis first reported a position in Legend Biotech in Q3 2021 and has held it in 18 quarters since.
  • Natixis's Legend Biotech position peaked at $377K in Q4 2021.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.